{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-274612","form_type":"8-K","ticker":"SGHT","cik":"0001531177","company_name":"Sight Sciences, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.401212+00:00","generated_at":"2026-06-08T06:39:38.696674+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Five MACs classify Sight Sciences' OMNI procedures as investigational; 63% of revenue at risk","bullets":["Four new MACs (Palmetto, Celerian, NGS, Noridian) plus prior WPS LCD classify OMNI canaloplasty/trabeculotomy as investigational, effective Dec 24, 2023.","The five MACs cover states representing ~63% of Sight Sciences' 2022 Surgical Glaucoma revenue.","LCDs trigger 'Reimbursement Trigger Event' under MidCap credit agreement; monthly principal payments begin Jan 2024.","If LCDs take effect, company may breach revenue covenant in 2024, allowing lender to accelerate repayment of $35M term loan.","Company plans to engage MACs and CMS to delay or reconsider; intends to pursue reconsideration if implemented."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-274612","json":"https://secwatch.observer/filing/0001193125-23-274612.json","markdown":"https://secwatch.observer/filing/0001193125-23-274612.md","text":"https://secwatch.observer/filing/0001193125-23-274612.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531177/000119312523274612/0001193125-23-274612-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531177/000119312523274612/d393470d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:39:38.696674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}